SIRS-Lab GmbH
Industry
- Biotechnology
- In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
See more in Biomedtracker
Latest on SIRS-Lab GmbH
In Vivo
Device Transactions In the second quarter of 2013, device companies raised $1.06 billion (45 transactions), on par with the $1.1 billion amassed in the previous quarter for about the same number of de
In Vivo
IN VITRO DIAGNOSTICS Mergers & Acquisitions Analytik Jena AG SIRS-Lab GMBH Life sciences firm Analytik Jena AG has acquired all of the assets of insolvent molecular diagnostics firm SIRS-Lab GMB
Medtech Insight
by Anne Staylor In this era of health care reform, critical care medicine remains a strong market for innovative technologies that can diagnose and treat patients faster, improve patient outcomes, sho